BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25604727)

  • 1. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study.
    Langkamp-Henken B; Rowe CC; Ford AL; Christman MC; Nieves C; Khouri L; Specht GJ; Girard SA; Spaiser SJ; Dahl WJ
    Br J Nutr; 2015 Feb; 113(3):426-34. PubMed ID: 25604727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial.
    Culpepper T; Christman MC; Nieves C; Specht GJ; Rowe CC; Spaiser SJ; Ford AL; Dahl WJ; Girard SA; Langkamp-Henken B
    Benef Microbes; 2016 Jun; 7(3):327-36. PubMed ID: 26839075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial.
    Manzano S; De Andrés J; Castro I; Rodríguez JM; Jiménez E; Espinosa-Martos I
    Benef Microbes; 2017 Aug; 8(4):569-578. PubMed ID: 28555502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effect of three probiotic strains on infants' gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study.
    De Andrés J; Manzano S; García C; Rodríguez JM; Espinosa-Martos I; Jiménez E
    Benef Microbes; 2018 Jun; 9(4):573-584. PubMed ID: 29726280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.
    de Vrese M; Winkler P; Rautenberg P; Harder T; Noah C; Laue C; Ott S; Hampe J; Schreiber S; Heller K; Schrezenmeir J
    Clin Nutr; 2005 Aug; 24(4):481-91. PubMed ID: 16054520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: a randomised, double-blind, placebo-controlled study.
    Xiao L; Gong C; Ding Y; Ding G; Xu X; Deng C; Ze X; Malard P; Ben X
    Benef Microbes; 2019 Oct; 10(7):729-739. PubMed ID: 31965842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects.
    Messaoudi M; Lalonde R; Violle N; Javelot H; Desor D; Nejdi A; Bisson JF; Rougeot C; Pichelin M; Cazaubiel M; Cazaubiel JM
    Br J Nutr; 2011 Mar; 105(5):755-64. PubMed ID: 20974015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
    Rizzardini G; Eskesen D; Calder PC; Capetti A; Jespersen L; Clerici M
    Br J Nutr; 2012 Mar; 107(6):876-84. PubMed ID: 21899798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students.
    Hughes C; Davoodi-Semiromi Y; Colee JC; Culpepper T; Dahl WJ; Mai V; Christman MC; Langkamp-Henken B
    Am J Clin Nutr; 2011 Jun; 93(6):1305-11. PubMed ID: 21525194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probiotics on digestibility and immunity in infants: A study protocol for a randomized controlled trial.
    Xiao L; Ding G; Ding Y; Deng C; Ze X; Chen L; Zhang Y; Song L; Yan H; Liu F; Ben X
    Medicine (Baltimore); 2017 Apr; 96(14):e5953. PubMed ID: 28383398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Immune Modulation of TLR3-Mediated Inflammation in Intestinal Epithelial Cells Differs between Single and Multi-Strain Probiotic Combination.
    MacPherson CW; Shastri P; Mathieu O; Tompkins TA; Burguière P
    PLoS One; 2017; 12(1):e0169847. PubMed ID: 28099447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
    J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of probiotics to reduce common cold in schoolchildren.
    Rerksuppaphol S; Rerksuppaphol L
    Pediatr Int; 2012 Oct; 54(5):682-7. PubMed ID: 22507276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.
    Kim JY; Kwon JH; Ahn SH; Lee SI; Han YS; Choi YO; Lee SY; Ahn KM; Ji GE
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e386-93. PubMed ID: 19840300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics (
    Dennis-Wall JC; Culpepper T; Nieves C; Rowe CC; Burns AM; Rusch CT; Federico A; Ukhanova M; Waugh S; Mai V; Christman MC; Langkamp-Henken B
    Am J Clin Nutr; 2017 Mar; 105(3):758-767. PubMed ID: 28228426
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression.
    Romijn AR; Rucklidge JJ; Kuijer RG; Frampton C
    Aust N Z J Psychiatry; 2017 Aug; 51(8):810-821. PubMed ID: 28068788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers.
    Messaoudi M; Violle N; Bisson JF; Desor D; Javelot H; Rougeot C
    Gut Microbes; 2011; 2(4):256-61. PubMed ID: 21983070
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.